We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBRX icon
2876
Forte Biosciences
FBRX
$1.57B
$28.4K ﹤0.01%
1,635
-4
-0.2% -$70
DC icon
2877
Dakota Gold
DC
$804M
$28.3K ﹤0.01%
+11,934
New +$25.8K
VEEE icon
2878
Twin Vee PowerCats
VEEE
$4.85M
$27.1K ﹤0.01%
85
-4
-4% -$1.87K
OGI
2879
Organigram Holdings
OGI
$139M
$26.4K ﹤0.01%
12,281
-71,727
-85% -$139K
SES icon
2880
SES AI
SES
$208M
$25.8K ﹤0.01%
15,328
BRTX icon
2881
BioRestorative Therapies
BRTX
$5.2M
$25.1K ﹤0.01%
+18,167
New +$28K
LNZAW icon
2882
LanzaTech Global Warrant
LNZAW
$24.3K ﹤0.01%
97,700
ABAT icon
2883
American Battery Technology Co
ABAT
$356M
$23.7K ﹤0.01%
+13,537
New +$34.6K
ADAP
2884
DELISTED
Adaptimmune Therapeutics
ADAP
$22.9K ﹤0.01%
+14,474
New +$17.5K
PED icon
2885
PEDEVCO
PED
$141M
$21.5K ﹤0.01%
1,338
CADL icon
2886
Candel Therapeutics
CADL
$776M
$21.2K ﹤0.01%
+13,409
New +$19.9K
SCTL
2887
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$21.1K ﹤0.01%
+19,500
New +$12.6K
HLLY.WS
2888
DELISTED
Holley Inc Warrants
HLLY.WS
$20.7K ﹤0.01%
59,100
KPTI icon
2889
Karyopharm Therapeutics
KPTI
$48M
$20.7K ﹤0.01%
913
-8,572
-90% -$150K
ADVWW
2890
DELISTED
Advantage Solutions Warrant
ADVWW
$20.6K ﹤0.01%
158,100
-5,000
-3% -$510
ADTHW
2891
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$19.8K ﹤0.01%
+132,300
New +$17.5K
ATYR
2892
aTyr Pharma
ATYR
$50.1M
$19.7K ﹤0.01%
10,088
-16,450
-62% -$28.7K
CNTB
2893
Connect Biopharma Holdings
CNTB
$139M
$18.8K ﹤0.01%
10,805
-600
-5% -$729
ALGS icon
2894
Aligos Therapeutics
ALGS
$34.9M
$18.3K ﹤0.01%
745
RBOT
2895
DELISTED
Vicarious Surgical
RBOT
$17.7K ﹤0.01%
1,953
-3,087
-61% -$36.8K
NEUP
2896
Neuphoria Therapeutics
NEUP
$20.6M
$17.6K ﹤0.01%
1,423
-1,183
-45% -$15.6K
ASTR
2897
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$16.9K ﹤0.01%
+24,722
New +$37.1K
GAN
2898
DELISTED
GAN Ltd
GAN
$16.7K ﹤0.01%
13,116
-21,484
-62% -$31.8K
ENVB icon
2899
Enveric Biosciences
ENVB
$6.24M
$15.4K ﹤0.01%
+86
New +$16.6K
DDC icon
2900
DDC Enterprise Ltd
DDC
$20.6M
$15.3K ﹤0.01%
+500
New +$27.2K

Similar funds

Two Sigma Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.

  • Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
  • Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
  • Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.